Published 19th November 2015

IXICO announces acquisition of Optimal Medicine

Portfolio company IXICO, the brain health company, has announced its intention to acquire Optimal Medicine. The Company is also proposing to raise approximately £2.7 million before expenses by way of a conditional placing at the Placing Price of 30.5p per share.

Professor Derek Hil, CEO of IXICO, noted:

"Optimal Medicine is a personalised medicine company which develops web based Digital Healthcare products that aid clinical decision making to improve patient outcomes. The addition of Optimal Medicine is in line with the Company’s stated strategy to broaden IXICO’s product offering through acquisition and gives it a foothold in the US, the biggest Digital Healthcare market globally."

To learn more about the acquisition, please click here.